Tumoritropic and lymphotropic principles of macromolecular drugs.

Hiroshi Maeda(Kumamoto University), Yasuhiro Matsumura(The Rogosin Institute)

PubMed

January 1, 1989

Cited by 580

Related Papers

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

|PubMed|1986|6.8k

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

|Journal of Controlled Release|2000|6.5k

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

|Advanced Drug Delivery Reviews|2010|3.5k

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

|Advances in Enzyme Regulation|2001|2.5k

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

|Advanced Drug Delivery Reviews|2012|2.3k